Document Detail

Preterm birth reduces the incidence of atopy in adulthood.
MedLine Citation:
PMID:  21333345     Owner:  NLM     Status:  Publisher    
BACKGROUND: Immunologic pathways are primed in early life. Preterm birth can influence this process and thereby affect whether a person will have atopy later in life. Previous studies on the effects of preterm birth on atopy in adulthood have been inconclusive and limited to children or subjects born moderately preterm. OBJECTIVE: Our aim was to compare the incidence of atopy among young adults who were born preterm and at very low birth weight (≤1500 g) with that of term-born young adults (control subjects). METHODS: The study comprised 166 adults who were born preterm and at very low birth weight and 172 control subjects, all of whom were from the Helsinki Study of Very Low Birth Weight Adults. We assessed atopic predisposition at ages 18 to 27 years using skin prick tests for 6 common aeroallergens and measurements of serum concentrations of total IgE and 3 types of allergen-specific (cat, birch, and timothy) IgE. We asked the subjects whether they had been given a diagnosis of asthma or allergic rhinitis or had atopic eczema and analyzed data by using logistic or linear regression, adjusting for potential confounding factors. RESULTS: The risk for having at least 1 positive reaction on a skin prick test was reduced (adjusted odds ratio, 0.43; 95% CI, 0.23-0.79, P = .007), and the concentration of cat-specific IgE was less (25% less; 95% CI, 43% to 2.3% less; P = .033) in sera from very-low-birth-weight subjects compared with that seen in sera from control subjects. Within the very-low-birth-weight group, those born at an earlier gestational age were less likely to have positive skin prick test reactions (adjusted odds ratio for 1 week, 0.82; 95% CI, 0.68-0.98, P = .029) and less likely to have high levels of allergen-specific IgE. Cumulative incidences of atopic disease were similar between adults of very low birth weight and control subjects. CONCLUSIONS: Young adults born prematurely and at very low birth weight have a lower incidence of atopy than adults who were born full term. This finding supports the hypothesis that the risk for atopy is determined during early stages of development.
Mirjami Siltanen; Karoliina Wehkalampi; Petteri Hovi; Johan G Eriksson; Sonja Strang-Karlsson; Anna-Liisa Järvenpää; Sture Andersson; Eero Kajantie
Related Documents :
25138715 - New clinical practice guidelines on the classification, evaluation and management of ch...
1253045 - Rubella 1974 and its aftermath, congenital rubella syndrome.
21531025 - Levels and profiles of pcdd/fs, pcbs in mothers' milk in shenzhen of china: estimation ...
2976555 - The activities of the hungarian centre for congenital anomaly control.
19438395 - Vivax malaria: a major cause of morbidity in early infancy.
18187215 - The independent and combined risk of diabetes and non-endstage renal impairment in non-...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-17
Journal Detail:
Title:  The Journal of allergy and clinical immunology     Volume:  -     ISSN:  1097-6825     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1275002     Medline TA:  J Allergy Clin Immunol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Division of Welfare and Health Promotion, Department of Chronic Disease Prevention, Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland; Hyvinkää Hospital, Hyvinkää, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Relationships among environmental exposures, cord blood cytokine responses, allergy, and wheeze at 1...
Next Document:  House dust mite sublingual immunotherapy: results of a US trial.